Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.135 AUD | 0.00% | +3.85% | -20.59% |
Apr. 08 | Starpharma, Medicxi Co-Found Petalion Therapeutics; Shares Surge 16% | MT |
Mar. 18 | Starpharma Holdings Limited(ASX:SPL) dropped from S&P/ASX Emerging Companies Index | CI |
Sales 2022 | 5.16M 3.37M | Sales 2023 | 4.21M 2.74M | Capitalization | 127M 82.99M |
---|---|---|---|---|---|
Net income 2022 | -16M -10.44M | Net income 2023 | -15M -9.78M | EV / Sales 2022 | 50.5 x |
Net cash position 2022 | 41.73M 27.22M | Net cash position 2023 | 26.91M 17.55M | EV / Sales 2023 | 23.8 x |
P/E ratio 2022 |
-18.5
x | P/E ratio 2023 |
-7.75
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 92.68% |
1 week | +3.85% | ||
Current month | +8.00% | ||
1 month | +3.85% | ||
3 months | -6.90% | ||
6 months | -3.57% | ||
Current year | -20.59% |
Managers | Title | Age | Since |
---|---|---|---|
Cheryl Maley
CEO | Chief Executive Officer | - | Jan. 07 |
Justin Cahill
DFI | Director of Finance/CFO | - | 23-04-02 |
Tony Eglezos
PRN | Corporate Officer/Principal | - | 13-08-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Davies
BRD | Director/Board Member | - | 22-03-31 |
Robert Thomas
CHM | Chairman | 79 | 13-12-03 |
David McIntyre
BRD | Director/Board Member | 53 | 20-02-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.135 | 0.00% | 139,014 |
24-04-24 | 0.135 | +8.00% | 115,702 |
24-04-23 | 0.125 | -3.85% | 279,417 |
24-04-22 | 0.13 | 0.00% | 547,549 |
24-04-19 | 0.13 | +4.00% | 313,928 |
Delayed Quote Australian S.E., April 26, 2024 at 02:10 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.59% | 36.28M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- SPL Stock